Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
85.04
+1.55 (1.86%)
At close: Mar 9, 2026, 4:00 PM EDT
85.04
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Kymera Therapeutics Employees
Kymera Therapeutics had 238 employees as of December 31, 2025. The number of employees increased by 50 or 26.60% compared to the previous year.
Employees
238
Change (1Y)
50
Growth (1Y)
26.60%
Revenue / Employee
$164,752
Profits / Employee
-$1,308,197
Market Cap
6.94B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Axsome Therapeutics | 925 |
| Arrowhead Pharmaceuticals | 711 |
| Cytokinetics | 673 |
| Halozyme Therapeutics | 423 |
| Rhythm Pharmaceuticals | 414 |
| Krystal Biotech | 295 |
| Cogent Biosciences | 258 |
| Nuvalent | 228 |
KYMR News
- 6 days ago - Kymera Therapeutics: Well-Funded Pipeline Enters A Defining Clinical Phase - Seeking Alpha
- 11 days ago - Kymera Therapeutics, Inc. (KYMR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Kymera Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - GlobeNewsWire
- 7 weeks ago - Kymera Therapeutics, Inc. (KYMR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs - GlobeNewsWire
- 3 months ago - Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 3 months ago - Kymera Therapeutics Announces Proposed Public Offering - GlobeNewsWire
- 3 months ago - This Drugmaker's Stock Is Soaring Over 40% Monday - Investopedia